Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2026)

Regeneron Pharmaceuticals has reported Shares Repurchased for 9 years, with the latest figure at $794.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased fell 23.73% year-over-year to $794.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 billion (down 4.83% YoY), and the FY2025 full-year result was $3.4 billion, up 32.09% from the prior year.
• Shares Repurchased for Q1 2026 stood at $794.3 million, up from $671.7 million in the prior quarter.
• The five-year high for Shares Repurchased was $1.1 billion in Q2 2025, with the low at $289.0 million in Q4 2023.
• Average Shares Repurchased over 5 years is $656.1 million, with a median of $671.7 million recorded in 2025.
• Year-over-year, Shares Repurchased soared 461.66% in 2022 and slumped 59.01% in 2024.
• Tracing REGN's Shares Repurchased over 5 years: stood at $431.1 million in 2022, then slumped by 32.96% to $289.0 million in 2023, then surged by 236.68% to $973.0 million in 2024, then sank by 30.97% to $671.7 million in 2025, then gained by 18.25% to $794.3 million in 2026.
• The last three Shares Repurchased figures came in at $794.3 million (Q1 2026), $671.7 million (Q4 2025), and $664.0 million (Q3 2025), per Business Quant data.

Peer Comparison